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August 11, 2009:661–8n heart failure patients treated with either ultrafiltration or
iuretics to achieve equivalent fluid removal, sustained hemody-
amic and neurohormonal benefit occurred only in the ultrafiltra-
ion group. Compared with the diuretic group, patients treated
ith ultrafiltration had lower norepinephrine, plasma renin, and
ldosterone levels for up to 90 days. Lower RAAS activation was
ssociated with sustained improvement in objective measures of
unctional capacity. The rate of 14 to 15 ml/min for interstitial
uid mobilization was outlined still earlier by Fauchald and
auchald (4), as recently reviewed by Schrier (5).
The conclusions of Rogers et al. (6) about the impact of
iuretics and ultrafiltration on renal function might or might not
e verified in larger trials. However, we feel strongly that the
mportant outcomes in subsequent studies involving patients hos-
italized with heart failure remain focused on a reduction of
ardiovascular mortality and heart failure rehospitalizations, rather
han on the more specific end point of renal function. This is
here we propose that new tactics are needed.
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s it Myocarditis or
rrhythmogenic Right
entricular Cardiomyopathy?
ieroni et al. (1) conclude that right ventricular myocarditis
requently mimics arrhythmogenic right ventricular cardiomyopa-
hy (ARVC), and 3-dimensional electroanatomic mapping (guided
ndomyocardial biopsy is a tool that can differentiate the 2 entities,
uiding appropriate therapy. The gist of their message suggests chat these 2 entities are mutually exclusive, and in their cohort,
lectrocardiographic abnormalities, arrhythmias, right ventricular
tructural and functional abnormalities, Task Force criteria fulfill-
ent, a 3-dimensional voltage map, and inducible arrhythmias on
lectrophysiologic testing could not separate the wheat from the
haff. Some experts have suggested that a “hot phase” may
nterpolate periods of clinical quiescence, and the former may
resent as myocarditis or worsening ventricular arrhythmia (2). If
e were to acknowledge the possibility of this alternative hypoth-
sis, the findings may be interpreted differently. The 15 patients
ho were diagnosed with myocarditis may represent a hot phase,
nd although they did not have fibrofatty changes, they fulfilled
ask Force criteria, which are quite specific for the diagnosis of the
isease. These patients with myocarditis may represent an earlier
hase of the disease, and the observation that none of these
atients experienced arrhythmic events gives credence to this
ossibility. Genetic testing in this sample would have been highly
esirable even though it is not considered necessary for diagnosis
y the authors. We agree with the authors that a revision and
eappraisal of diagnostic criteria for ARVC is long overdue.
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yocarditis Mimicking
rrhythmogenic Right
entricular Cardiomyopathy
e have read with interest the paper by Pieroni et al. (1)
ddressing myocarditis as a common differential diagnosis to
rrhythmogenic right ventricular cardiomyopathy (ARVC).
mong 30 patients noninvasively fulfilling Task Force criteria (2)
or ARVC, they found that 15 patients actually had myocarditis
ased on 3-dimensional electroanatomic voltage mapping-guided
ndomyocardial biopsy. Voltage-guided biopsy is an elegant way of
btaining histological material from areas of the right ventricle
ith electrical signs of regional abnormalities and may facilitate the
iagnostic workup. However, we have the following questions/
oncerns about the study by Pieroni et al. (1):
